Almonertinib Plus Metronomic Oral Vinorelbine

Clinical trial NCT05663177 · UNKNOWN

Trial details

NCT number: NCT05663177
Sponsor: Fujian Cancer Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

EGFR NSCLC Third-generation TKI

Start date: 2022-12-20
Primary completion: 2023-12-20
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.